Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray Baron

Showing results (201-210 of 281) with videos related to

Pageof 29
Sort By:
Journal of Scleroderma and Related Disorders|June 8, 2026
Scleroderma Clinical Trials Consortium (SCTC) outcome instruments for evaluation of systemic sclerosisAntonia Valenzuela, Lorinda Chung, John D Pauling, et al.
The European Respiratory Journal|December 22, 2012
High prevalence of occult left heart disease in scleroderma-pulmonary hypertensionBenjamin D Fox, Avi Shimony, David Langleben, et al.
Rheumatology (Oxford, England)|December 26, 2016
Clinical correlates of faecal incontinence in systemic sclerosis: identifying therapeutic avenuesNicolas Richard, Marie Hudson, Geneviève Gyger, et al.
Clinical and Experimental Rheumatology|September 6, 2018
Determinants of health-related quality of life in a multinational systemic sclerosis inception cohortKathleen Morrisroe, Marie Hudson, Murray Baron, et al.
Plos One|January 18, 2013
Cross-language measurement equivalence of the Center for Epidemiologic Studies Depression (CES-D) scale in systemic sclerosis: a comparison of Canadian and Dutch patientsLinda Kwakkenbos, Erin Arthurs, Frank H J van den Hoogen, et al.
Rheumatology (Oxford, England)|January 10, 2023
Prediction of damage trajectories in systemic sclerosis using group-based trajectory modellingMurray Baron, Ariane Barbacki, Ada Man, et al.
Annals of the Rheumatic Diseases|April 1, 2019
Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosisNava Ferdowsi, Molla Huq, Wendy Stevens, et al.
The Journal of Rheumatology|November 18, 2008
Demographic and clinical factors associated with physician service use in systemic sclerosisSasha Bernatsky, Pantelis Panopolis, Marie Hudson, et al.
Seminars in Arthritis and Rheumatism|July 4, 2016
Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: A Scleroderma Clinical Trials Consortium studyAntonia Valenzuela, Murray Baron, , et al.
Seminars in Arthritis and Rheumatism|February 20, 2022
Change in calcinosis over 1 year using the scleroderma clinical trials consortium radiologic scoring system for calcinosis of the hands in patients with systemic sclerosisAntonia Valenzuela, Kathryn Stevens, Melody P Chung, et al.
Pageof 29

Showing results (201-210 of 281) with videos related to

Sort By:
Pageof 29
Journal of Scleroderma and Related Disorders|June 8, 2026
Scleroderma Clinical Trials Consortium (SCTC) outcome instruments for evaluation of systemic sclerosisAntonia Valenzuela, Lorinda Chung, John D Pauling, et al.
The European Respiratory Journal|December 22, 2012
High prevalence of occult left heart disease in scleroderma-pulmonary hypertensionBenjamin D Fox, Avi Shimony, David Langleben, et al.
Rheumatology (Oxford, England)|December 26, 2016
Clinical correlates of faecal incontinence in systemic sclerosis: identifying therapeutic avenuesNicolas Richard, Marie Hudson, Geneviève Gyger, et al.
Clinical and Experimental Rheumatology|September 6, 2018
Determinants of health-related quality of life in a multinational systemic sclerosis inception cohortKathleen Morrisroe, Marie Hudson, Murray Baron, et al.
Plos One|January 18, 2013
Cross-language measurement equivalence of the Center for Epidemiologic Studies Depression (CES-D) scale in systemic sclerosis: a comparison of Canadian and Dutch patientsLinda Kwakkenbos, Erin Arthurs, Frank H J van den Hoogen, et al.
Rheumatology (Oxford, England)|January 10, 2023
Prediction of damage trajectories in systemic sclerosis using group-based trajectory modellingMurray Baron, Ariane Barbacki, Ada Man, et al.
Annals of the Rheumatic Diseases|April 1, 2019
Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosisNava Ferdowsi, Molla Huq, Wendy Stevens, et al.
The Journal of Rheumatology|November 18, 2008
Demographic and clinical factors associated with physician service use in systemic sclerosisSasha Bernatsky, Pantelis Panopolis, Marie Hudson, et al.
Seminars in Arthritis and Rheumatism|July 4, 2016
Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: A Scleroderma Clinical Trials Consortium studyAntonia Valenzuela, Murray Baron, , et al.
Seminars in Arthritis and Rheumatism|February 20, 2022
Change in calcinosis over 1 year using the scleroderma clinical trials consortium radiologic scoring system for calcinosis of the hands in patients with systemic sclerosisAntonia Valenzuela, Kathryn Stevens, Melody P Chung, et al.
Pageof 29